Eli Lilly expands manufacturing network through new factory acquisition
Eli Lilly is once again increasing its production capacity after the US-based pharmaceutical company reached an agreement with Nexus Pharmaceuticals on a deal that will transfer a factory to Eli Lilly, the companies state in a stock exchange announcement.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lilly’s new USD 2.5bn plant to boost obesity drug supply
For subscribers
Shortage of Eli Lilly's obesity drug in US becomes official
For subscribers